Skip to main content
. 2020 Feb 13;15(2):e0229186. doi: 10.1371/journal.pone.0229186

Table 3. Characteristics of laboratory tests and invasive procedures.

Test/Procedures STEMI (N = 455)
Mean(SD) or N(%)
Initial CK (U/L) 206(105–568)
Initial CK-MB (U/L) 19(4–43)
Initial troponin (ng/mL) 0.75(0.05–12.4)
Peak CK (U/L) 1357(496–2728)
Peak CK-MB (U/L) 108(33–228.5)
Peak troponin (ng/mL) 25(2.76–80)
Creatinine (mg/dL) 1.03(0.8–1.4)
Hemoglobin (g/dL) 14.2(6.2)
HbA1c (%) 8.4(1.9)
Total cholesterol (mg/dL) 169.5(44.9)
HDL (mg/dL) 38.0(9.3)
LDL (mg/dL) 107.9(40.2)
Triglyceride (mg/dL) 152.7(117.0)
Stenosis of culprit lesion (%) 94.8(11.0)
Infarct-related artery
LM 4(0.9)
LAD 207(46.4)
LCx 54(12.1)
RCA 179(40.1)
Unknown 2(0.5)
Initial TIMI flow 0 245(53.8)
Number of diseased vessels
    0 0(0)
    1 188(41.3)
    2 113(24.8)
    3 145(31.9)
    Missing 9(2.0)

Abbreviations: CK, creatine kinase; CK-MB, creatine kinase myocardial band; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LAD, left anterior descending artery; LCx, left circumflex artery; LDL, low-density lipoprotein; LM, left main; RCA, right coronary artery; SD, standard deviation; STEMI, ST-segment elevation myocardial infarction; TIMI, Thrombolysis In Myocardial Infarction.